History

History — A Disciplined Cyclical, Handed Over at the Bottom

Somero Enterprises reports its financial statements in US dollars; its shares trade on London's AIM in pounds sterling. Figures here are stated as reported (USD) — no FX conversion is applied, so this USD presentation is identical to the native file. Ratios, margins, and multiples are unitless and unchanged.

Somero's story over the last five years is not one of a strategy that broke — it is one of a cycle that turned, narrated by a management team that mostly told the truth about it. The arc runs from a 2021–2022 boom ("the strongest financial position in our history" [1]) through a three-year, peak-to-trough revenue slide from $133.6m to $88.9m, and into an April 2025 leadership handover that ended a 27-year CEO tenure and rebranded the whole company as "Somero 3.0." What changed is the register of the story: from "record" to "comparable," from boom growth to a formal capital-allocation-and-M&A framework, from a founder-era operator to a hired-in industrial executive. What did not change is the discipline underneath — net cash, no debt, high through-cycle margins, and cash returned every single year. Management credibility is intact but no longer pristine: they call the cycle honestly once it has turned, but their year-ahead guidance at the turning points has been consistently too optimistic.

The arc at a glance

Sources: credibility score is this analyst's judgment (rationale below); leadership dates per FY2024 Annual Report [2] and FY2024 Annual Report [3]; revenue ratio derived from reported financials.

Source: FY2025 Annual Report, Chairman’s and CEO’s Statement [4]; FY2024 results, Financial Highlights [5]; FY2021–FY2022 figures from the respective Annual Reports.

The shape is unambiguous: 2021 and 2022 were twin peaks (revenue marginally higher in 2022 at $133.6m, but adjusted EBITDA already easing 3.8% to $46.0m), and every year since has been down — revenue 10% in 2023 [6], 9.5% in 2024, and 19% in 2025 [4]. Adjusted EBITDA has more than halved from $47.8m to roughly $17.5m. This is the central fact every other thread in the story hangs from.

Source: EBITDA margin per company results presentations; operating margin derived from reported financials, FY2021–FY2025.

The margin line tells you this is operating-leverage in reverse, not a structural break: gross margin held near 52–57% throughout, but as volume fell the fixed-cost base dragged operating margin from 32% to 16%. Somero never stopped being a high-return business; it simply rode a cyclical wave down. That distinction is what keeps the credibility verdict from being harsher.

The constant: a debt-free cash machine that pays you in the good years and less in the bad

Before the changes, the continuities — because they are the heart of the bull case for management. Across the entire window Somero carried no debt, ended each year in net cash, and returned cash to shareholders every year via an ordinary dividend plus a formulaic "supplemental" dividend set at 50% of year-end cash above a Board-approved $25.0m minimum reserve [7]. The discipline is real: the dividend is designed to fall with earnings, and it did, without drama or balance-sheet stress.

Source: derived from reported financials (Consolidated Statements of Cash Flows / Income), FY2022–FY2025; FY2024 ordinary dividend cut per FY2024 results, Dividend [8].

Cash returns fell in lock-step with profits — from a record $29.0m in 2022 to $9.3m in 2025 — and the ordinary dividend was cut three years running (10% in 2022, then 16.5%, then 27.1% in 2024 [8], then a further 40% to 10.2c in 2025 [9]). Crucially, this was not forced: FY2025 year-end net cash actually recovered to $33.2m [10]. The cuts tracked earnings by formula, not liquidity panic — exactly what a disciplined cyclical should do.

The other constant is the honesty of the risk disclosure. The "cyclical nature of the non-residential concrete construction industry" sat in the principal-risks list in 2021 as boilerplate [11] — and the identical phrase still sits there in 2025 [12]. The risk that wrecked the numbers was never hidden; it was always named. Management cannot be accused of pretending Somero was a secular grower.

The guidance track record: do they hit their own numbers?

This is where credibility is decided, and the pattern is specific: in-year (rebased) guidance is reliable; year-ahead guidance issued at a turning point is not. Somero has issued a timely trading update before each disappointment — June 2023, mid-2024, and the explicit 24 April 2025 warning that trading had been "weaker than expected" [13] — and then delivered "in line with revised market expectations" [5]. That phrase, repeated verbatim in 2024 and 2025, is itself a tell of honesty: it openly concedes the original number was missed and re-cut, rather than papering over it.

Sources: H1 2023 guidance [15] and FY2023 delivery "in line with guidance provided on 20 June 2023" [16]; FY2023 outlook for 2024 [17]; H1 2024 rebased guide [18]; FY2024 outlook for 2025 [19]; H1 2025 rebased guide [20].

The visual below isolates the credibility weakness: at each turning point, the year-ahead guide was meaningfully above what was delivered, while the mid-year rebased guide was accurate to within a rounding error.

Source: year-ahead guide interpreted from the prior-year qualitative outlook ("comparable" for 2024; "moderate growth on 2024" for 2025) per FY2023 AR [17] and FY2024 results [19]; rebased guides per H1 results [18][20]; actuals as reported.

One nuance keeps this from being damning. After H1 2025 revenue had already collapsed 23% [21], management reaffirmed a rebased full-year guide of c.$90.0m revenue / c.$18.0m EBITDA [20] — and the year landed at $88.9m. They were optimistic at the year-ahead horizon but accurate once they could see the order book. A reader should weight Somero's in-year guidance heavily and its year-ahead outlook lightly.

Narrative drift: from "record" to "comparable" to a process story

Read the five years in sequence and the language migrates in a way the numbers alone don't capture. In 2021 the company was "record breaking" and in "the strongest financial position in our history" [1], with international revenue up 50% [1] as proof the diversification thesis was working; by 2022 it was still "all-time high" in Europe and Australia [23]. Then the verbs flatten: every outlook from FY2022 onward promises revenue merely "comparable" to the prior year [24][17], and by FY2025 the very best on offer is "broadly comparable to 2025" [25].

The heatmap shows what management emphasized — and quietly stopped emphasizing — year by year.

Source: analyst coding of Annual Report and results-presentation emphasis, FY2021–FY2025; key markers cited throughout this page (e.g. Somero 3.0 framework [26]; capital allocation and M&A frameworks [27]).

Three drifts matter. First, the boom vocabulary vanished entirely after 2022 — there is no "record" framing once revenue rolled over, which is appropriate but worth naming. Second, M&A and a named strategy framework appear from nowhere in 2025: "Somero 3.0 – Shaping Excellence" with its FORTIFY / INNOVATE / AMPLIFY pillars debuts in the September 2025 deck [26], and a formal Capital Allocation Framework plus a dedicated Mergers and Acquisitions Framework are institutionalised in the March 2026 deck [27]. A reader should read this charitably as a new CEO bringing process — but also skeptically: a process narrative is what companies reach for when the growth narrative has stalled.

Third — the quiet one — is the capacity claim that the business grew away from rather than into. In 2021 the expanded Houghton, Michigan plant was sized for "$175.0m" of revenue [28]; a year later that was upgraded to "over $200.0m in revenue" [29]. Revenue then went the other way, to $88.9m. The capacity was built for a company more than twice the size of the one that exists today — a forecasting optimism that, while not dishonest, the later filings simply stopped mentioning.

There was also genuine strategic retrenchment beneath the growth talk: Somero divested its direct China operations at the end of 2023 [30], even as it kept pushing Europe (Belgium) and electrified products. The "international diversification" theme survived, but it became narrower and more selective than the 2021 version.

The leadership handover: a 27-year founder-era CEO replaced at the bottom of the cycle

The most important structural event in the period is the leadership transition, and the dates matter because every other tab uses them to separate what this team did from what it inherited.

The succession was not panicked — the FY2024 report shows the board had "engaged an executive search firm" and run a formal process [33] — and the new CEO is a credible industrial operator: 30 years in the field, most recently COO of Stoughton Trailers, before that Group President at Astec Industries and 22 years at Deere and Company [34]. Management framed it as a "smooth leadership transition" [4].

The inherited-quality call is unambiguous: Averkamp inherited a fundamentally high-quality business — debt-free, historically 30%+ EBITDA margins, dominant in its laser-screed niche, strongly cash-generative — but caught mid-downcycle. He did not build or fix the quality; he was handed it at a low point in the cycle. That framing should anchor the capital-allocation assessment elsewhere in the report: the current team's track record is barely a year old, and the new M&A ambition is unproven. One early governance wrinkle is worth flagging — several resolutions, including the remuneration report, failed to pass at the June 2026 AGM [35] — a sign that shareholders are scrutinising the new regime closely.

Credibility verdict

Source: this analyst's judgment, built from the cited guidance-vs-delivery and capital-allocation record above.

Score: 7 / 10. The verdict rests on a clean separation between two kinds of behaviour. On honesty and discipline, Somero scores high: it named cyclicality as its top risk in identical words for five straight years [11][12], issued a timely profit warning before every disappointment [13], took fast cost action, used the candid "in line with revised expectations" formulation rather than spinning a miss as a hit [5], and ran a textbook, formula-driven dividend that fell honestly with earnings while the balance sheet stayed pristine [10]. This is management that tells you the truth when it misses.

What caps the score below 8 is forecasting and framing at the turns: the year-ahead "moderate growth" guide for 2025 was badly wrong [19], the $200m-capacity optimism was quietly dropped as the business shrank to $89m [29], and the 2025 pivot to a branded strategy-and-M&A framework reads partly as a process narrative substituting for absent growth [27]. Of the eight valuation-relevant guides reviewed, five were met (all the in-year/rebased ones) and three were missed (all the year-ahead ones issued before the cycle visibly turned). That is a 7: trustworthy, disciplined, but not clairvoyant — and now operating under a leadership team with only a year on the clock.

What the story is now

The narrative today is simpler and more honest than the boom-era story, but more uncertain than at any point in the window. What has been de-risked: the balance sheet (net cash $33.2m, no debt [10]), the earnings base (a 19% revenue decline still produced positive operating cash flow and a 20% EBITDA margin), and expectations (the 2026 guide of "broadly comparable to 2025" [25] is the most conservative in years and the easiest to clear).

What still looks stretched: the M&A pivot is brand-new, unproven, and funded partly by suspending the supplemental dividend and redirecting cash into an enlarged buyback [36] — a real change in capital-allocation philosophy from a team without a deal track record. And the return to growth is entirely a cyclical bet on North American non-residential construction recovering; nothing in the 2025–2026 disclosure suggests management can manufacture growth in a flat end-market.

What to believe versus discount: believe the discipline, the cash returns, the in-year guidance, and the honest accounting of misses — that culture is five years deep in the record. Discount the long-term growth framework and the M&A ambition until there are deals and integration to judge, and treat any year-ahead growth guidance with caution given the turning-point track record. Credibility is best described as stable-to-slightly-deteriorating: the honesty is undimmed, but the predictive track record weakened through the downturn, and the unproven new strategy adds execution risk that did not exist when Cooney ran a single, simple, cash-returning machine. The next two years — the first real test of the Averkamp team and its M&A framework — will decide whether the "Somero 3.0" story earns the trust the old story had built.